Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment
Richard I G Holt, Clive S Cockram, Ronald C W Ma , Andrea O Y Luk
Diabetologia. 2024 Jul;67(7):1168-1180.
doi: 10.1007/s00125-024-06102-x
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic, Katherine R Tuttle, Peter Rossing, et al,N Engl J Med. 2024 May 24.
doi: 10.1056/NEJMoa2403347
Atypical Diabetes: What Have We Learned and What Does the Future Hold?
Stephen I Stone, Ashok Balasubramanyam, Jennifer E Posey
Diabetes Care. 2024 May 1;47(5):770-781.
doi.org/10.2337/dci23-0038
Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure
Katherine L Modzelewski, Alexandra Pipilas, Nicholas A Bosch
JAMA Netw Open . 2024 May 1;7(5):e249305.
doi.org/10.1001/jamanetworkopen.2024.9305
The value of loss of protective pain sensation in predicting a first ulceration of the foot in people with diabetes
Anna Trocha, Veronika Gontscharuk, Andrea Icks, William Jeffcoate
Diabet Med. 2024 Apr;41(4):e15241. d
https://doi.org/10.1111/dme.15241
Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use
David B Sacks, M Sue Kirkman, Randie R Little.
Diabetes Care. 2024 Mar 29:dci230040.
doi: 10.2337/dci23-0040.
Comentarios recientes